Conmebol confirma calendario para la Libertadores: Colo Colo y UC juegan en septiembre

12.03.2020.COLO COLO VS ATLETICO PARANAENSE_ESTADIO MONUMENTAL_COPA LIBERTADORES_FUTBOL_RESULTADO 1 A 0 A FAVOR DE COLO COLO_FOTO: ESTEBAN GALINDO FAGETT/LA CUARTA
12.03.2020.COLO COLO VS ATLETICO PARANAENSE_ESTADIO MONUMENTAL_COPA LIBERTADORES_FUTBOL_RESULTADO 1 A 0 A FAVOR DE COLO COLO_FOTO: ESTEBAN GALINDO FAGETT/LA CUARTA

La reprogramación se realizó debido al coronavirus que afecta al continente.

Esta tarde la Conmebol confirmó el nuevo fixture que tendrá la Copa Libertadores 2020. De esta forma el torneo se seguirá jugando recién en septiembre de este año por culpa del covid-19 que afecta al continente.

De esta forma Colo Colo será el primer equipo chileno en saltar a la cancha. El Cacique recibirá a Peñarol el 15 de septiembre a las 19:15 horas por el grupo C y el encuentro será televisado por Fox Sports.

Tras ello, los albos viajarán a Brasil para medirse ante Paranaense el 23 del mismo mes a las 19:15 horas. Luego, Colo Colo viajará a Uruguay para enfrentarse a Peñarol el 29/09 a las 20:15 horas.

La fase de grupos finalizará el 20 de septiembre a las 21:30 horas, cuando reciba a Jorge Wilstermann en el Monumental.

En tanto Universidad Católica hará lo propio al día siguiente ante Gremio a las 21:30 horas. El encuentro del 16 de septiembre en San Carlos de Apoquindo por el grupo E también será transmitido por la señal premium.

Luego los cruzados viajarán a Colombia para enfrentar a América de Cali el 23 de septiembre a las 19:30 horas. Después tocará viajar a Brasil para visitar a Gremio en Porto Alegre. Partido pactado para el 29/09 a las 19:15 horas.

La fase de grupos finalizará de local en San Carlos contra Inter a las 21:30 horas el 22 de septiembre.

REVISA EL CALENDARIO COMPLETO:

In this handout photo released by the University of Oxford samples from coronavirus vaccine trials are handled inside the Oxford Vaccine Group laboratory in Oxford, England Thursday June 25, 2020. Scientists at Oxford University say their experimental coronavirus vaccine has been shown in an early trial to prompt a protective immune response in hundreds of people who got the shot. In research published Monday July 20, 2020 in the journal Lancet, scientists said that they found their experimental COVID-19 vaccine produced a dual immune response in people aged 18 to 55. (John Cairns, University of Oxford via AP)
In this handout photo released by the University of Oxford samples from coronavirus vaccine trials are handled inside the Oxford Vaccine Group laboratory in Oxford, England Thursday June 25, 2020. Scientists at Oxford University say their experimental coronavirus vaccine has been shown in an early trial to prompt a protective immune response in hundreds of people who got the shot. In research published Monday July 20, 2020 in the journal Lancet, scientists said that they found their experimental COVID-19 vaccine produced a dual immune response in people aged 18 to 55. (John Cairns, University of Oxford via AP)
In this handout photo released by the University of Oxford samples from coronavirus vaccine trials are handled inside the Oxford Vaccine Group laboratory in Oxford, England Thursday June 25, 2020. Scientists at Oxford University say their experimental coronavirus vaccine has been shown in an early trial to prompt a protective immune response in hundreds of people who got the shot. In research published Monday July 20, 2020 in the journal Lancet, scientists said that they found their experimental COVID-19 vaccine produced a dual immune response in people aged 18 to 55. (John Cairns, University of Oxford via AP)
In this handout photo released by the University of Oxford samples from coronavirus vaccine trials are handled inside the Oxford Vaccine Group laboratory in Oxford, England Thursday June 25, 2020. Scientists at Oxford University say their experimental coronavirus vaccine has been shown in an early trial to prompt a protective immune response in hundreds of people who got the shot. In research published Monday July 20, 2020 in the journal Lancet, scientists said that they found their experimental COVID-19 vaccine produced a dual immune response in people aged 18 to 55. (John Cairns, University of Oxford via AP)

Temas Relacionados

COMPARTIR NOTA